BAM
TTOO

Brave Asset Management’s T2 Biosystems, Inc TTOO Stock Holding History

Brave Asset Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed -$3K – 162
2022
Q3 		$3K Hold
5
– – ﹤0.01% 150
2022
Q2 		$4K Hold
5
– – ﹤0.01% 147
2022
Q1 		$14K Hold
5
– – ﹤0.01% 156
2021
Q4 		$14K Hold
5
– – ﹤0.01% 154
2021
Q3 		$24K Buy
5
+1
+25% +$5.03K 0.01% 151
2021
Q2 		$23K Buy
+4
New +$25.8K 0.01% 154

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Brave Asset Management's TTOO Position: Q4 2022 in Review

Brave Asset Management sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 5 shares — an estimated $3K sold.

Brave Asset Management first reported a position in TTOO in Q2 2021 and held it in 6 quarters. The position peaked at $24K in Q3 2021. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Brave Asset Management reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Brave Asset Management sold 5 T2 Biosystems, Inc shares in Q4 2022, an estimated $3K.
  • Brave Asset Management first reported a position in T2 Biosystems, Inc in Q2 2021 and held it in 6 quarters.
  • Brave Asset Management's T2 Biosystems, Inc position peaked at $24K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Brave Asset Management's 13F filing for Q4 2022, filed 20 Jan 2023.